Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial. - Wikidata - awgldk - TriplyDB

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

http://www.wikidata.org/entity/Q43877058

about

Antipsychotic medication for early episode schizophrenia Efficacy of atypical v. typical antipsychotics in the treatment of early psychosis: meta-analysis Pharmacologic treatment of schizophrenia Efficacy and safety of individual second-generation vs. first-generation antipsychotics in first-episode psychosis: a systematic review and meta-analysis Long-term outcomes of antipsychotic treatment in patients with first-episode schizophrenia: a systematic review Randomized controlled trials in schizophrenia: opportunities, limitations, and trial design alternatives Current Data on and Clinical Insights into the Treatment of First Episode Nonaffective Psychosis: A Comprehensive Review The evolution of drug development in schizophrenia: past issues and future opportunities.Prescription practices in the treatment of first-episode schizophrenia spectrum disorders: data from the national RAISE-ETP study The association of dropout and outcome in trials of antipsychotic medication and its implications for dealing with missing data.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: long-term treatment of schizophrenia.Excessive weight gain after remission of depression in a schizophrenic patient treated with risperidone: case report.Appraising evidence for intervention effectiveness in early psychosis: conceptual framework and review of evaluation approaches.The 2009 schizophrenia PORT psychopharmacological treatment recommendations and summary statements The effects of novel and newly approved antipsychotics on serum prolactin levels: a comprehensive review.Onset of action of atypical and typical antipsychotics in the treatment of acute psychosis Modern antipsychotic drugs: a critical overview Trajectories and antecedents of treatment response over time in early-episode psychosis.Schizophrenia (maintenance treatment).Risk of osteoporosis and fracture incidence in patients on antipsychotic medication.World Federation of Societies of Biological Psychiatry (WFSBP) guidelines for biological treatment of schizophrenia, part 2: update 2012 on the long-term treatment of schizophrenia and management of antipsychotic-induced side effects.Medication-free research in early episode schizophrenia: evidence of long-term harm?Atypical antipsychotics and pituitary tumors: a pharmacovigilance study.Methodological issues in current antipsychotic drug trials.World Federation of Societies of Biological Psychiatry (WFSBP) Guidelines for Biological Treatment of Schizophrenia, part 1: update 2012 on the acute treatment of schizophrenia and the management of treatment resistance.Almost all antipsychotics result in weight gain: a meta-analysis.Past and present progress in the pharmacologic treatment of schizophrenia.Preventing the second episode: a systematic review and meta-analysis of psychosocial and pharmacological trials in first-episode psychosis Incidence of tardive dyskinesia with atypical versus conventional antipsychotic medications: a prospective cohort study Olanzapine vs. risperidone in patients with first-episode schizophrenia and a lifetime history of cannabis use disorders: 16-week clinical and substance use outcomes.The treatment of schizophrenia: from premorbid manifestations to the first episode of psychosis.Aripiprazole versus haloperidol treatment in early-stage schizophrenia.A single blind comparative clinical study of the effects of chlorpromazine and risperidone on positive and negative symptoms in patients of schizophrenia Quantifying clinical relevance in the treatment of schizophrenia.Relapse prevention in schizophrenia: a systematic review and meta-analysis of second-generation antipsychotics versus first-generation antipsychotics Teaching trainees to negotiate research collaborations with industry: a mentorship model.Tolerability and efficacy of paliperidone ER compared to olanzapine in the treatment of schizophrenia: A randomized, double-blind, multicentric trial Very low-dose risperidone in first-episode psychosis: a safe and effective way to initiate treatment Long-term tolerability of once-monthly injectable paliperidone palmitate in subjects with recently diagnosed schizophrenia.Current schizophrenia drugs: efficacy and side effects.

P2860

Q24236683-086BD04E-E545-4455-B0E1-56B1B1311619 Q24603049-809D7256-0B41-4944-9097-5CA40715A89A Q24604457-D2BE5CEA-F3AE-421B-B26E-4AA9155D633D Q24606868-F98704E7-15B2-4831-9A2C-9AB87E109701 Q26770497-0CFC7D1B-A9B7-482E-BC09-C2750AD3717E Q26863435-BDD2F6BE-A29B-4782-90C6-E1E9BBFC363C Q28079821-A5FC85C0-025B-40F0-A3BF-5C98103603C6 Q30487850-E7AC2F7F-836D-434C-935F-69D69BBACC17 Q30627430-78DE3095-491C-4A5D-B77F-CE58D4F9974D Q31143463-43D7EC72-8F67-43CF-88EC-CA5D41FAC6E7 Q33235110-ECE73D7C-9840-490A-99F4-1884E45C9B9D Q33256430-3E0B3B18-BCCE-47B0-B414-D58F7B3944C3 Q33533853-06046F54-0C46-4480-90FE-BF35DB78911C Q33566124-63E87A7C-C2A6-4E31-B24A-DCB4927E09CF Q33619940-FE58C24A-F0E8-4E3F-B0CA-D09E8ACFEAE2 Q33828080-4D88CE84-0181-489B-8D42-568C47D55AA6 Q33853390-776B84AD-350C-4196-BA8A-F15223C6A6BB Q33890123-D9358611-8B02-4AD1-BB5C-98FE4B80CD85 Q34010697-9D2E9ACC-7B97-4105-A390-3F0F1482C37A Q34026011-674AC2A0-6C49-48C3-8F31-E32D2EB35DC9 Q34315836-F015F4A6-58E0-41BC-9033-5D4DB3B83489 Q34463497-A2606EA7-EBDF-45D7-81F3-B54E2E1A2C15 Q34529081-B7318B8C-8486-422A-88D2-876A081C6F98 Q34587745-1EA88A68-2EAC-4A80-861B-055D53FD575B Q34640811-D88E4C42-6814-43AC-8F5B-2E4AD5E92791 Q34661499-0F072B14-F39D-4C2B-A954-8EE18A183203 Q34726953-F2587907-C184-4140-822A-03AE8641AB9A Q34830869-D538446A-1D19-45C1-9718-3058ACA46504 Q35030003-1BA7DF21-9C39-429A-9DC8-776269354CB3 Q35136787-1E87F42F-4532-40DD-B2C3-D06A10B98573 Q35236574-931C8E2B-6F9C-4F31-B9D8-0C0F0CD23038 Q35684487-F0CBE021-E385-4C40-A93D-436313D7CAE7 Q35732320-3AC02901-DA4C-4A84-870D-7990E1B38960 Q35819467-5ABA3FB1-407E-45EE-82C4-26B2EEB806A8 Q35873789-156939AE-1288-4363-BABD-F69F190AFA40 Q35920534-F59CFA71-C457-4803-B1C3-943FACC0C725 Q36181958-7F0CCBCD-D496-4E06-9488-37DB2A4AF853 Q36192422-EC121956-BE0B-48C1-BA6D-3B7B423C77AE Q36202865-9DB3B9C8-1C51-4F0F-A5F8-9CF5FC16AA49 Q36488206-179A7B8A-8A25-4151-A87F-C4C8511804FF

P2860

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

http://www.wikidata.org/entity/Q43877058

description

2005 nî lūn-bûn

@nan

2005年の論文

@ja

2005年学术文章

@wuu

2005年学术文章

@zh

2005年学术文章

@zh-cn

2005年学术文章

@zh-hans

2005年学术文章

@zh-my

2005年学术文章

@zh-sg

2005年學術文章

@yue

2005年學術文章

@zh-hant

name

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

@en

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

@nl

type

label

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

@en

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

@nl

prefLabel

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

@en

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

@nl

P1433

Q43877058-F0908609-3BC5-462A-A490-37D573DE48F2

P1476

Q43877058-4192A181-C301-4F90-850B-73EFC260B731

P2093

Q43877058-13B1117B-6A3F-430A-9E7B-EFD4DDCEBFD3

Q43877058-1DDEA8F1-6AE8-4F9D-8BAE-E14613906E63

Q43877058-3E4574CE-AAAF-4F33-9040-2CCE5A5DC995

Q43877058-5D24F3FD-6247-4C51-BBDE-D8B0BE2EC65E

Q43877058-66FBED46-3262-48D8-9D65-F9D9EEC6295B

Q43877058-81DEB67F-122D-4955-BBB7-8E7C9A022687

Q43877058-A5085F2B-E3EB-45C6-BFAE-F3273925B386

Q43877058-A581297B-E1B0-42D7-8C0A-7A21D23BFF96

Q43877058-B2A7B709-B159-4492-9D17-0510E087E16B

Q43877058-B5F17807-A990-49C1-BAF2-F996C547C7E0

P304

Q43877058-0341ADAF-E5C1-40D0-9D3D-D001AC194180

P31

Q43877058-F48FF190-5E93-406D-BAC3-C2C3BD0A1AFE

P356

Q43877058-41344F69-AD75-4590-8EDD-27FCAB3FA7B7

P407

Q43877058-22CDF108-0EAA-4BE2-B6EB-6467E1DE48BA

P433

Q43877058-64D5771D-B70D-4400-B7DB-673D0F9D9F27

P478

Q43877058-7561B78A-96B4-4C25-93BF-17721C511F8B

P50

Q43877058-6378ADD2-9740-410A-8A0C-D43E11D2461B

P577

Q43877058-DE31F1F0-5EE4-4335-AFF6-AC40C0F83946

P5875

Q43877058-4FBD60F9-D64C-4FD3-9AF6-58823BE34298

P698

Q43877058-3C6E77D9-CD24-4945-852B-41DFE5A6F883

P921

Q43877058-D1FD2648-E902-4374-A2B0-8B8CCC3633DC

P356

APPI.AJP.162.5.947

P1433

American Journal of Psychiatry

P1476

Risperidone and haloperidol in first-episode psychosis: a long-term randomized trial.

@en

P2093

Early Psychosis Global Working Group

http://www.w3.org/2001/XMLSchema#string

Goedele De Smedt

http://www.w3.org/2001/XMLSchema#string

Ilse Van Hove

http://www.w3.org/2001/XMLSchema#string

Jonathan Rabinowitz

http://www.w3.org/2001/XMLSchema#string

Lili Kopala

http://www.w3.org/2001/XMLSchema#string

Marielle Eerdekens

http://www.w3.org/2001/XMLSchema#string

Michael Davidson

http://www.w3.org/2001/XMLSchema#string

Nina Schooler

http://www.w3.org/2001/XMLSchema#string

Patrick D McGorry

http://www.w3.org/2001/XMLSchema#string

Robin Emsley

http://www.w3.org/2001/XMLSchema#string

P304

947-953

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1176/APPI.AJP.162.5.947

http://www.w3.org/2001/XMLSchema#string

P407

P433

5

http://www.w3.org/2001/XMLSchema#string

P478

162

http://www.w3.org/2001/XMLSchema#string

P50

Philip D. Harvey

P577

2005-05-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

7873982

http://www.w3.org/2001/XMLSchema#string

P698

15863797

http://www.w3.org/2001/XMLSchema#string

P921